Capital DailyCapital Daily
Finance

Germany's Merck to buy Bio-Techne for $11.3 billion

Merck ​KGaA ​has ​agreed to acquire biotech firm Bio-Techne for $11.3 billion, the ⁠German ‌science and healthcare ⁠firm said in a statement on Thursday.

CD
Capital Daily Newsroom
Editorial Desk
· 2 min read
𝕏 in ✉
Germany's Merck to buy Bio-Techne for $11.3 billion

Germany's Merck to buy Bio-Techne for $11.3 billion

Published June 25, 2026 · Category: Finance

Overview

Merck ​KGaA ​has ​agreed to acquire biotech firm Bio-Techne for $11.3 billion, the ⁠German ‌science and healthcare ⁠firm said in a statement on Thursday.

Source

Originally published at www.cnbc.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.

Related Stories

More from Financial News →
Micron Just Eliminated Its Biggest Risk With This Brilliant Move, and Investors Are Loving it
Finance

Micron Just Eliminated Its Biggest Risk With This Brilliant Move, and Investors Are Loving it
Cost Conscious? Vanguard S&P 500 ETF Tops SPDR Rival
Finance

Cost Conscious? Vanguard S&P 500 ETF Tops SPDR Rival
Should You Really Buy Tech Stocks Now? History Offers a Surprising Answer That's Strikingly Clear.
Finance

Should You Really Buy Tech Stocks Now? History Offers a Surprising Answer That's Strikingly Clear.
The Lime IPO Offers Excitement, but This Stock Will Be the Better Long-Term Moneymaker
Finance

The Lime IPO Offers Excitement, but This Stock Will Be the Better Long-Term Moneymaker